Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypesBrian D. Lehmann(Vanderbilt University), X. Steven Chen(University of Miami)Nature CommunicationsNovember 1, 202110.1038/s41467-021-26502-6Cited by 255SaveCiteExport RISWatch citationsRelated PapersPIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors|Breast Cancer Research|2014|331Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue|BMC Cancer|2017|54